Study quality ratings adapted from the National Institutes of Health quality assessment tools for observational cohort and cross-sectional studies
Study (year) . | Research question or objective is clear . | Study population is specified and defined . | Participation rate is reported and is ≥50% . | Inclusion and exclusion criteria are clear, and all participants come from the same sample . | Sample size justification, power description, or variance and effect estimates are provided . | Cortisol measure is clearly defined and assessed with valid and reliable methods . | Total . |
---|---|---|---|---|---|---|---|
Hair cortisol | |||||||
Hollister et al28 (2021) | 1 | 1 | 0 | 1 | 0 | 1 | 4 |
Salivary cortisol | |||||||
Kölbel et al29 (2022) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Serum cortisol | |||||||
Akinlade et al30 (2013) | 1 | 1 | 0 | 1 | 0 | 0 | 4 |
Akinlade et al31 (2013) | 1 | 1 | 0 | 1 | 0 | 0 | 4 |
Bashir et al32 (1993) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
El-Sonbaty et al33 (2016) | 1 | 1 | 0 | 1 | 0 | 1 | 4 |
Garadah et al34 (2016) | 1 | 1 | 0 | 1 | 0 | 1 | 4 |
Groom et al35 (1990) | 1 | 1 | 0 | 1 | 0 | 0 | 4 |
Hagag et al36 (2015) | 1 | 1 | 0 | 1 | 0 | 1 | 4 |
Soliman et al37 (1995) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Soliman et al38 (1995) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Solomon et al39 (2012) | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Plasma cortisol | |||||||
Adams et al40 (2017) | 1 | 1 | 0 | 1 | 0 | 0 | 3 |
el-Hazmi et al41 (1992) | 1 | 1 | 0 | 0 | 0 | 0 | 3 |
el-Hazmi et al42 (1994) | 1 | 1 | 0 | 0 | 0 | 0 | 3 |
Grewen et al43 (2012) | 1 | 1 | 0 | 0 | 0 | 0 | 2 |
Osifo et al44 (1988) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Rosenbloom et al45 (1980) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Saad and Saad46 (1992) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Sobngwi et al47 (2018) | 1 | 1 | 0 | 1 | 1 | 1 | 5 |
Study (year) . | Research question or objective is clear . | Study population is specified and defined . | Participation rate is reported and is ≥50% . | Inclusion and exclusion criteria are clear, and all participants come from the same sample . | Sample size justification, power description, or variance and effect estimates are provided . | Cortisol measure is clearly defined and assessed with valid and reliable methods . | Total . |
---|---|---|---|---|---|---|---|
Hair cortisol | |||||||
Hollister et al28 (2021) | 1 | 1 | 0 | 1 | 0 | 1 | 4 |
Salivary cortisol | |||||||
Kölbel et al29 (2022) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Serum cortisol | |||||||
Akinlade et al30 (2013) | 1 | 1 | 0 | 1 | 0 | 0 | 4 |
Akinlade et al31 (2013) | 1 | 1 | 0 | 1 | 0 | 0 | 4 |
Bashir et al32 (1993) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
El-Sonbaty et al33 (2016) | 1 | 1 | 0 | 1 | 0 | 1 | 4 |
Garadah et al34 (2016) | 1 | 1 | 0 | 1 | 0 | 1 | 4 |
Groom et al35 (1990) | 1 | 1 | 0 | 1 | 0 | 0 | 4 |
Hagag et al36 (2015) | 1 | 1 | 0 | 1 | 0 | 1 | 4 |
Soliman et al37 (1995) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Soliman et al38 (1995) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Solomon et al39 (2012) | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Plasma cortisol | |||||||
Adams et al40 (2017) | 1 | 1 | 0 | 1 | 0 | 0 | 3 |
el-Hazmi et al41 (1992) | 1 | 1 | 0 | 0 | 0 | 0 | 3 |
el-Hazmi et al42 (1994) | 1 | 1 | 0 | 0 | 0 | 0 | 3 |
Grewen et al43 (2012) | 1 | 1 | 0 | 0 | 0 | 0 | 2 |
Osifo et al44 (1988) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Rosenbloom et al45 (1980) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Saad and Saad46 (1992) | 1 | 1 | 0 | 0 | 0 | 1 | 3 |
Sobngwi et al47 (2018) | 1 | 1 | 0 | 1 | 1 | 1 | 5 |